The etonogestrel implant is the most effective method of birth control with a 0.5% failure rate in the first year. Despite this, almost half of women discontinue the implant because of method dissatisfaction, often due to bothersome vaginal bleeding. Prior studies have been small and not focused on adolescents and young adults. Our objective was to identify medical and demographic factors that are predictive of early ( < 12 months of use) removal of the implant due to bothersome bleeding in adolescents.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Pediatric and Adolescent Gynecology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect